No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Thiogenesis Announces Presentation on UMDF Webcast Featuring Clinical Trials in Mitochondrial Disease
Thiogenesis Announces DTC Eligibility in the U.S. and Other Updates
Thiogenesis Announces Important Core Patent Allowed in Europe
Thiogenesis Announces Investor Relations Engagement
Thiogenesis Proposes Phase 2 Trial to Evaluate Its NASH Treatment
Thiogenesis Announces Collaboration and Updates on Pediatric NASH Clinical Program
No Data